Enjoy Free Shipping with orders of $175 or more!
Multiple Sclerosis
Sativex for the management of multiple sclerosis symptoms (PubMed)
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis(PubMed)
Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis(PubMed)
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(PubMed)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (European Journal of Neurology)
Cannabinoid Modulation of Neuroinflammatory Disorders (Current Neuropharmacology)
Cannabinoids and multiple sclerosis (Pharmacology and Therapeutics)
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up (J Neurol Neurosurg Psychiatry)
Cannabinoids in the management of spasticity associated with multiple sclerosis (Neuropsychiatric Disease and Treatment)
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study (Multiple Sclerosis Journal)
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review (BioMed Central)